We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
High-dose CD34+cells are not clinically relevant in reducing cytopenia and blood component consumption following myeloablative therapy and peripheral blood progenitor cell transplantation as compared with standard dose.
- Authors
Lefrere, Francois; Delarue, Richard; Somme, Dominique; Levy, Vincent; Damaj, Ghandi; Tu, Angela; Porcher, Raphael; Audat, Francois; Boulat, Claire; Cavazzana-Calvo, Marine; Buzyn, Agnes; Belanger, Coralie; Maillard, Natacha; Hermine, Olivier; Varet, Bruno
- Abstract
Studies the relevance of high-dose CD34+ in reducing cytopenia and blood component consumption following myeloablative therapy and peripheral blood progenitor cell (PBPC) transplantation as compared with standard dose. Examination of the effects of CD34+ cell transfusions in patients with myeloma; Assessment of PBPC collection; Indication and modality for blood component transfusion.
- Subjects
HEMAPHERESIS; BLOOD transfusion; MYELOMA proteins
- Publication
Transfusion, 2002, Vol 42, Issue 4, p443
- ISSN
0041-1132
- Publication type
Article
- DOI
10.1046/j.1525-1438.2002.00060.x